Patent · US Active

Biomarkers for seizures

US11035866B2 · kind B2 · utility

0Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2018
Grant dateJun 15, 2021
Priority date
Expiry dateMay 11, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2857
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The application relates to markers for seizures and epilepsy. Polypeptide expression panels or arrays are provided, comprising one or more probes capable of binding specific polypeptides in blood plasma or blood serum of a mammalian subject. Also provided are methods for detecting seizure, methods for predicting seizure, use of sICAM-5 in the treatment of seizure, methods for assessing the effectiveness of a treatment of seizure, and diagnostic kits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.